Akoya Biosciences Ownership 2024 | Who Owns Akoya Biosciences Now?
Institutional Ownership
25.18%
Insider Ownership
11.60%
Retail Ownership
63.22%
Institutional Holders
60.00
Akoya Biosciences Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLUE WATER LIFE SCIENCE ADVISORS, LP | 9.55% | 10.69% | 4,697,785 | - | - | 10,992,817 | Jun 30, 2024 |
| BLACKROCK INC. | 3.05% | 0.00% | 1,501,887 | 154,348 | 11.45% | 3,514,415 | Jun 30, 2024 |
| VANGUARD GROUP INC | 2.98% | 0.00% | 1,463,853 | 9,565 | 0.66% | 3,425,416 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.14% | 0.00% | 562,123 | 48,074 | 9.35% | 1,315,500 | Jun 30, 2024 |
| SVB WEALTH LLC | 1.05% | 0.03% | 515,317 | - | - | 1,205,842 | Jun 30, 2024 |
| STATE STREET CORP | 0.88% | - | 434,935 | 6,608 | 1.54% | 1,017,748,000 | Jun 30, 2024 |
| PARKMAN HEALTHCARE PARTNERS LLC | 0.76% | 0.12% | 375,536 | -541,906 | -59.07% | 878,754 | Jun 30, 2024 |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 0.71% | 2.00% | 350,000 | 350,000 | 100.00% | 819,000 | Jun 30, 2024 |
| POLAR CAPITAL HOLDINGS PLC | 0.67% | 0.00% | 329,756 | -1,250,000 | -79.13% | 771,629 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.60% | 0.00% | 294,342 | -81,158 | -21.61% | 688,760 | Jun 30, 2024 |
| PEDDOCK CAPITAL ADVISORS, LLC | 0.48% | 0.14% | 234,926 | -5,124 | -2.13% | 549,727 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.43% | 0.00% | 209,717 | 2,322 | 1.12% | 490,738,000 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.37% | 0.01% | 179,600 | 159,100 | 776.10% | 420,264 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.36% | 0.00% | 175,888 | 4,112 | 2.39% | 411,578 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.34% | 0.03% | 165,766 | 150,001 | 951.48% | 388,000 | Jun 30, 2024 |
| OSTERWEIS CAPITAL MANAGEMENT INC | 0.26% | 0.02% | 126,131 | - | - | 295,147 | Jun 30, 2024 |
| MORGAN STANLEY | 0.22% | - | 108,184 | 44,418 | 69.66% | 253,152 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.14% | - | 67,468 | 9,429 | 16.25% | 157,875 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.13% | 0.00% | 65,949 | -72,329 | -52.31% | 154,321 | Jun 30, 2024 |
| ZWJ INVESTMENT COUNSEL INC | 0.09% | 0.00% | 46,475 | 1,300 | 2.88% | 108,752 | Jun 30, 2024 |
Akoya Biosciences's largest institutional shareholder is BLUE WATER LIFE SCIENCE ADVISORS, LP, holding 9.55% of the company's total share outstanding, currently valued at $10.99M. The top 10 institutional shareholders own together 21.40% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLUE WATER LIFE SCIENCE ADVISORS, LP | 9.55% | 10.69% | 4,697,785 | - | - | 10,992,817 | Jun 30, 2024 |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 0.71% | 2.00% | 350,000 | 350,000 | 100.00% | 819,000 | Jun 30, 2024 |
| PEDDOCK CAPITAL ADVISORS, LLC | 0.48% | 0.14% | 234,926 | -5,124 | -2.13% | 549,727 | Jun 30, 2024 |
| PARKMAN HEALTHCARE PARTNERS LLC | 0.76% | 0.12% | 375,536 | -541,906 | -59.07% | 878,754 | Jun 30, 2024 |
| SVB WEALTH LLC | 1.05% | 0.03% | 515,317 | - | - | 1,205,842 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.34% | 0.03% | 165,766 | 150,001 | 951.48% | 388,000 | Jun 30, 2024 |
| OSTERWEIS CAPITAL MANAGEMENT INC | 0.26% | 0.02% | 126,131 | - | - | 295,147 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.37% | 0.01% | 179,600 | 159,100 | 776.10% | 420,264 | Jun 30, 2024 |
| ZWJ INVESTMENT COUNSEL INC | 0.09% | 0.00% | 46,475 | 1,300 | 2.88% | 108,752 | Jun 30, 2024 |
| POLAR CAPITAL HOLDINGS PLC | 0.67% | 0.00% | 329,756 | -1,250,000 | -79.13% | 771,629 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.60% | 0.00% | 294,342 | -81,158 | -21.61% | 688,760 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.04% | 0.00% | 18,984 | -6,135 | -24.42% | 44,423 | Jun 30, 2024 |
| REGAL INVESTMENT ADVISORS LLC | 0.04% | 0.00% | 18,760 | 7,340 | 64.27% | 43,899 | Jun 30, 2024 |
| QUADRATURE CAPITAL LTD | 0.08% | 0.00% | 39,891 | 39,891 | 100.00% | 92,946 | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.01% | 0.00% | 6,727 | 5,414 | 412.34% | 15,741 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.13% | 0.00% | 65,949 | -72,329 | -52.31% | 154,321 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.03% | 0.00% | 14,295 | 14,295 | 100.00% | 33,450 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.14% | 0.00% | 562,123 | 48,074 | 9.35% | 1,315,500 | Jun 30, 2024 |
| HIGHTOWER ADVISORS, LLC | 0.06% | 0.00% | 27,200 | - | - | 63,000 | Jun 30, 2024 |
| AMERITAS INVESTMENT PARTNERS, INC. | 0.00% | 0.00% | 1,199 | - | - | 2,806 | Jun 30, 2024 |
The largest Akoya Biosciences shareholder by % of total assets is BLUE WATER LIFE SCIENCE ADVISORS, LP. The company owns 4.70M shares of Akoya Biosciences (AKYA), representing 10.69% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 0.71% | 2.00% | 350,000 | 350,000 | 100.00% | 819,000 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.37% | 0.01% | 179,600 | 159,100 | 776.10% | 420,264 | Jun 30, 2024 |
| BLACKROCK INC. | 3.05% | 0.00% | 1,501,887 | 154,348 | 11.45% | 3,514,415 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.34% | 0.03% | 165,766 | 150,001 | 951.48% | 388,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.14% | 0.00% | 562,123 | 48,074 | 9.35% | 1,315,500 | Jun 30, 2024 |
| MORGAN STANLEY | 0.22% | - | 108,184 | 44,418 | 69.66% | 253,152 | Jun 30, 2024 |
| QUADRATURE CAPITAL LTD | 0.08% | 0.00% | 39,891 | 39,891 | 100.00% | 92,946 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 0.04% | - | 19,370 | 19,370 | 100.00% | 45,326 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.03% | 0.00% | 14,295 | 14,295 | 100.00% | 33,450 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.02% | 0.00% | 11,389 | 11,389 | 100.00% | 26,650 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.04% | - | 20,660 | 10,962 | 113.03% | 48,343 | Jun 30, 2024 |
| VANGUARD GROUP INC | 2.98% | 0.00% | 1,463,853 | 9,565 | 0.66% | 3,425,416 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.14% | - | 67,468 | 9,429 | 16.25% | 157,875 | Jun 30, 2024 |
| REGAL INVESTMENT ADVISORS LLC | 0.04% | 0.00% | 18,760 | 7,340 | 64.27% | 43,899 | Jun 30, 2024 |
| STATE STREET CORP | 0.88% | - | 434,935 | 6,608 | 1.54% | 1,017,748,000 | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | 0.07% | - | 33,050 | 5,900 | 21.73% | 77,337 | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.01% | 0.00% | 6,727 | 5,414 | 412.34% | 15,741 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.36% | 0.00% | 175,888 | 4,112 | 2.39% | 411,578 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.43% | 0.00% | 209,717 | 2,322 | 1.12% | 490,738,000 | Jun 30, 2024 |
| ROYAL BANK OF CANADA | 0.01% | - | 2,799 | 1,758 | 168.88% | 7,000 | Jun 30, 2024 |
As of Jun 30 2024, Akoya Biosciences's largest institutional buyer is PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE. The company purchased 350.00K stocks of AKYA, valued at $819.00K.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| POLAR CAPITAL HOLDINGS PLC | 0.67% | 0.00% | 329,756 | -1,250,000 | -79.13% | 771,629 | Jun 30, 2024 |
| UNIPLAN INVESTMENT COUNSEL, INC. | - | - | - | -699,837 | -100.00% | - | Jun 30, 2024 |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | - | - | - | -580,834 | -100.00% | - | Jun 30, 2024 |
| PARKMAN HEALTHCARE PARTNERS LLC | 0.76% | 0.12% | 375,536 | -541,906 | -59.07% | 878,754 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.60% | 0.00% | 294,342 | -81,158 | -21.61% | 688,760 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.13% | 0.00% | 65,949 | -72,329 | -52.31% | 154,321 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -50,421 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -28,981 | -100.00% | - | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.05% | 0.00% | 22,200 | -28,500 | -56.21% | 51,948 | Jun 30, 2024 |
| MARSHALL WACE, LLP | - | - | - | -22,017 | -100.00% | - | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | - | - | - | -18,406 | -100.00% | - | Jun 30, 2024 |
| SHERBROOKE PARK ADVISERS LLC | - | - | - | -15,960 | -100.00% | - | Jun 30, 2024 |
| AMERIPRISE FINANCIAL INC | 0.04% | - | 19,700 | -15,150 | -43.47% | 46,098 | Jun 30, 2024 |
| UBS GROUP AG | 0.02% | - | 8,162 | -13,287 | -61.95% | 19,099 | Jun 30, 2024 |
| STEPHENS INC /AR/ | - | - | - | -12,471 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -11,425 | -100.00% | - | Jun 30, 2024 |
| STIFEL FINANCIAL CORP | - | - | - | -10,729 | -100.00% | - | Jun 30, 2024 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | - | - | - | -10,656 | -100.00% | - | Jun 30, 2024 |
| BARCLAYS PLC | 0.02% | - | 9,377 | -8,551 | -47.70% | 21,000 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.04% | 0.00% | 18,984 | -6,135 | -24.42% | 44,423 | Jun 30, 2024 |
As of Jun 30 2024, Akoya Biosciences's biggest institutional seller is POLAR CAPITAL HOLDINGS PLC. The company sold -1.25M shares of AKYA, valued at $771.63K.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 0.71% | 2.00% | 350,000 | 350,000 | 100.00% | 819,000 | Jun 30, 2024 |
| QUADRATURE CAPITAL LTD | 0.08% | 0.00% | 39,891 | 39,891 | 100.00% | 92,946 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 0.04% | - | 19,370 | 19,370 | 100.00% | 45,326 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.03% | 0.00% | 14,295 | 14,295 | 100.00% | 33,450 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.02% | 0.00% | 11,389 | 11,389 | 100.00% | 26,650 | Jun 30, 2024 |
| STRS OHIO | 0.00% | - | 200 | 200 | 100.00% | 468,000 | Jun 30, 2024 |
| REDWOOD WEALTH MANAGEMENT GROUP, LLC | 0.00% | 0.00% | 30 | 30 | 100.00% | 70 | Jun 30, 2024 |
Akoya Biosciences's largest new institutional shareholder by number of shares is PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE, purchased 350.00K shares, valued at $819.00K, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| UNIPLAN INVESTMENT COUNSEL, INC. | - | - | - | -699,837 | -100.00% | - | Jun 30, 2024 |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | - | - | - | -580,834 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -50,421 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -28,981 | -100.00% | - | Jun 30, 2024 |
| MARSHALL WACE, LLP | - | - | - | -22,017 | -100.00% | - | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | - | - | - | -18,406 | -100.00% | - | Jun 30, 2024 |
| SHERBROOKE PARK ADVISERS LLC | - | - | - | -15,960 | -100.00% | - | Jun 30, 2024 |
| STEPHENS INC /AR/ | - | - | - | -12,471 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -11,425 | -100.00% | - | Jun 30, 2024 |
| STIFEL FINANCIAL CORP | - | - | - | -10,729 | -100.00% | - | Jun 30, 2024 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | - | - | - | -10,656 | -100.00% | - | Jun 30, 2024 |
| HIGHMARK WEALTH MANAGEMENT LLC | - | - | - | -4,000 | -100.00% | - | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -2,356 | -100.00% | - | Jun 30, 2024 |
| POINT72 (DIFC) LTD | - | - | - | -429 | -100.00% | - | Jun 30, 2024 |
| FARTHER FINANCE ADVISORS, LLC | - | - | - | -4 | -100.00% | - | Jun 30, 2024 |
Akoya Biosciences's largest sold out institutional shareholder by shares sold is UNIPLAN INVESTMENT COUNSEL, INC., sold -0.70M shares, valued at -, as of undefined.
Akoya Biosciences Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| ALGER INSTITUTIONAL FUNDS | 0.23% | 60,048 | - | - | Jan 31, 2024 |
| ALGER PORTFOLIOS | 0.16% | 61,494 | - | - | Dec 31, 2023 |
| ALGER FUNDS | 0.15% | 139,659 | - | - | Jan 31, 2024 |
| PRUDENTIAL SECTOR FUNDS, INC. | 0.08% | 176,846 | - | - | Feb 29, 2024 |
| ALLSPRING VARIABLE TRUST | 0.04% | 27,752 | - | - | Mar 31, 2024 |
| EXCHANGE TRADED CONCEPTS TRUST | 0.03% | 192,359 | - | - | Feb 29, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.03% | 17,202 | - | - | Mar 31, 2024 |
| FORUM FUNDS II | 0.02% | 19,359 | - | - | Jan 31, 2024 |
| LORD ABBETT SECURITIES TRUST | 0.02% | 89,804 | - | - | Jan 31, 2024 |
| FRANKLIN STRATEGIC SERIES | 0.02% | 156,009 | - | - | Jan 31, 2024 |
| SMALLCAP WORLD FUND INC | 0.01% | 700,000 | - | - | Mar 31, 2024 |
| Humankind Benefit Corp | 0.01% | 201 | - | - | Dec 31, 2023 |
| BRIDGEWAY FUNDS INC | 0.01% | 20,500 | 20,500 | - | Mar 28, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 40,656 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 3,812 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 1,188,433 | -236,110 | -16.57% | Mar 31, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.00% | 73,369 | - | - | Feb 29, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 59,741 | - | - | Jan 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 216,797 | 11,907 | 5.81% | Feb 29, 2024 |
| Federated Hermes Global Allocation Fund | 0.00% | 9,094 | - | - | Feb 29, 2024 |
| Columbia Funds Variable Series Trust II | 0.00% | 26,092 | - | - | Mar 31, 2024 |
| Federated Hermes Equity Funds | 0.00% | 11,830 | - | - | Jan 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 6,122 | - | - | Mar 31, 2024 |
| AMERICAN CENTURY STRATEGIC ASSET ALLOCATIONS INC | 0.00% | 6,338 | - | - | Jan 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 1,199 | - | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 11,780 | -1,306 | -9.98% | Mar 31, 2024 |
| VANGUARD WORLD FUND | 0.00% | 83,780 | 16,972 | 25.40% | Feb 29, 2024 |
| Series Portfolios Trust | 0.00% | 1,877 | 37 | 2.01% | Jan 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 1,416 | - | - | Mar 31, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 148,699 | 53,629 | 56.41% | Feb 29, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 7,873 | - | - | Mar 31, 2024 |
| Global X Funds | 0.00% | 7,038 | - | - | Jan 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 8,100 | - | - | Mar 31, 2024 |
| North Square Investments Trust | 0.00% | 1,010 | - | - | Jan 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 1,003 | - | - | Mar 31, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 4,991 | - | - | Feb 29, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 1,594 | 289 | 22.15% | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 8,568 | -2,992 | -25.88% | Mar 28, 2024 |
| EQ ADVISORS TRUST | 0.00% | 65,308 | - | - | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 109,112 | 20,621 | 23.30% | Feb 29, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 144 | - | - | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 789,929 | -22,957 | -2.82% | Mar 31, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 165 | - | - | Dec 31, 2023 |
| 1290 Funds | 0.00% | 48,581 | - | - | Jan 31, 2024 |
| VALIC Co I | 0.00% | 8,897 | 300 | 3.49% | Feb 29, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 3,898 | - | - | Mar 31, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 2,265 | - | - | Mar 31, 2024 |
| WILSHIRE MUTUAL FUNDS INC | 0.00% | 7,527 | - | - | Dec 31, 2023 |
| PENN SERIES FUNDS INC | 0.00% | 700 | - | - | Mar 28, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 82 | - | - | Dec 31, 2023 |
| ProFunds | 0.00% | 180 | -13 | -6.74% | Mar 31, 2024 |
| FLEXSHARES TRUST | 0.00% | 1,128 | - | - | Jan 31, 2024 |
| PROSHARES TRUST | 0.00% | 3,397 | 518 | 17.99% | Feb 29, 2024 |
| Dimensional ETF Trust | 0.00% | 5,833 | 5,821 | 48508.33% | Jan 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 40,437 | 11,207 | 38.34% | Jan 31, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 78 | - | - | Feb 29, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 2,993 | 519 | 20.98% | Jan 31, 2024 |
| T. Rowe Price Multi-Strategy Total Return Fund, Inc. | 0.00% | 1,837 | - | - | Jan 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 1,393 | -17 | -1.21% | Jan 31, 2024 |
| Franklin Alternative Strategies Funds | 0.00% | 5,431 | - | - | Feb 29, 2024 |
| VANGUARD QUANTITATIVE FUNDS | 0.00% | 47 | - | - | Mar 31, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 11 | - | - | Dec 31, 2023 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 767 | - | - | Feb 29, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 18,300 | - | - | Mar 31, 2024 |
| Brighthouse Funds Trust II | 0.00% | 6,387 | - | - | Mar 31, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 2,627 | 89 | 3.51% | Jan 31, 2024 |
| ADVANCED SERIES TRUST | 0.00% | 23,000 | - | - | Mar 28, 2024 |
| EMPOWER FUNDS, INC. | 0.00% | 6,947 | - | - | Mar 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 10,656 | 747 | 7.54% | Mar 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 4,136 | 4,136 | - | Jan 31, 2024 |
| ETF Series Solutions | 0.00% | 76 | - | - | Jan 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 11,519 | 1,443 | 14.32% | Mar 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 2,319 | - | - | Mar 31, 2024 |
| PACIFIC SELECT FUND | 0.00% | 6,034 | - | - | Mar 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 996 | - | - | Dec 31, 2023 |
| Bridge Builder Trust | 0.00% | 4,362 | - | - | Mar 31, 2024 |
| John Hancock Funds II | 0.00% | 11,162 | - | - | Feb 29, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 2,922 | - | - | Mar 31, 2024 |
| Meeder Funds | 0.00% | 3 | - | - | Mar 31, 2024 |
| BLACKROCK FUNDS | 0.00% | 3,420 | 2,734 | 398.54% | Jan 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 2,915 | 766 | 35.64% | Jan 31, 2024 |
Akoya Biosciences's largest mutual fund holder by % of total assets is "ALGER INSTITUTIONAL FUNDS", owning 60.05K shares, compromising 0.23% of its total assets.
Akoya Biosciences Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 60 | -11.76% |
| 31 Mar, 24 | 68 | 3.03% |
| 31 Dec, 23 | 66 | 3.13% |
| 30 Sep, 23 | 64 | -16.88% |
| 30 Jun, 23 | 77 | 18.46% |
| 31 Mar, 23 | 65 | -10.96% |
| 31 Dec, 22 | 73 | 19.67% |
| 30 Sep, 22 | 61 | 12.96% |
| 30 Jun, 22 | 54 | 17.39% |
| 31 Mar, 22 | 46 | 2.22% |
| 31 Dec, 21 | 45 | -4.26% |
| 30 Sep, 21 | 47 | -21.67% |
| 30 Jun, 21 | 60 | - |
As of 30 Jun 24, 60 institutions are holding Akoya Biosciences's shares, representing a decrease of -11.76% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 12,385,236 | -16.62% |
| 31 Mar, 24 | 14,854,121 | 0.66% |
| 31 Dec, 23 | 14,756,868 | -8.16% |
| 30 Sep, 23 | 16,067,868 | -1.98% |
| 30 Jun, 23 | 16,391,912 | 22.72% |
| 31 Mar, 23 | 13,357,414 | -5.06% |
| 31 Dec, 22 | 14,068,972 | -2.19% |
| 30 Sep, 22 | 14,383,381 | 10.79% |
| 30 Jun, 22 | 12,982,833 | 5.45% |
| 31 Mar, 22 | 12,312,215 | 1.45% |
| 31 Dec, 21 | 12,136,763 | 22.54% |
| 30 Sep, 21 | 9,904,230 | -1.59% |
| 30 Jun, 21 | 10,064,753 | - |
Akoya Biosciences (AKYA) has 12.39M shares outstanding as of 30 Jun 24, down -16.62% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 25.18% | 2.25% |
| 31 Mar, 24 | 33.43% | 3.68% |
| 31 Dec, 23 | 30.13% | 1.93% |
| 30 Sep, 23 | 39.54% | 2.16% |
| 30 Jun, 23 | 42.77% | 3.52% |
| 31 Mar, 23 | 34.85% | 2.51% |
| 31 Dec, 22 | 37.27% | 2.59% |
| 30 Sep, 22 | 37.95% | 3.19% |
| 30 Jun, 22 | 34.52% | 3.20% |
| 31 Mar, 22 | 32.86% | 1.61% |
| 31 Dec, 21 | 45.12% | 6.35% |
| 30 Sep, 21 | 26.65% | 2.36% |
| 30 Jun, 21 | 33.58% | - |
As of 30 Jun 24, Akoya Biosciences is held by 25.18% institutional shareholders, representing a 2.25% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 28 | -6.67% |
| 31 Mar, 24 | 30 | -14.29% |
| 31 Dec, 23 | 35 | -10.26% |
| 30 Sep, 23 | 39 | -23.53% |
| 30 Jun, 23 | 51 | 64.52% |
| 31 Mar, 23 | 31 | -13.89% |
| 31 Dec, 22 | 36 | - |
| 30 Sep, 22 | 36 | 5.88% |
| 30 Jun, 22 | 34 | 41.67% |
| 31 Mar, 22 | 24 | -20.00% |
| 31 Dec, 21 | 30 | 15.38% |
| 30 Sep, 21 | 26 | -56.67% |
| 30 Jun, 21 | 60 | - |
28 institutional shareholders have increased their position in AKYA stock as of 30 Jun 24 compared to 30 in the previous quarter (a -6.67% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 21 | -8.70% |
| 31 Mar, 24 | 23 | 9.52% |
| 31 Dec, 23 | 21 | 75.00% |
| 30 Sep, 23 | 12 | -7.69% |
| 30 Jun, 23 | 13 | -38.10% |
| 31 Mar, 23 | 21 | -4.55% |
| 31 Dec, 22 | 22 | 46.67% |
| 30 Sep, 22 | 15 | 25.00% |
| 30 Jun, 22 | 12 | -25.00% |
| 31 Mar, 22 | 16 | 100.00% |
| 31 Dec, 21 | 8 | -46.67% |
| 30 Sep, 21 | 15 | - |
| 30 Jun, 21 | - | - |
21 institutional shareholders have reduced their position in AKYA stock as of 30 Jun 24 compared to 23 in the previous quarter (a -8.70% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 60 | -11.76% | 12,385,236 | -16.62% | 25.18% | 2.25% | 28 | -6.67% | 21 | -8.70% |
| 31 Mar, 24 | 68 | 3.03% | 14,854,121 | 0.66% | 33.43% | 3.68% | 30 | -14.29% | 23 | 9.52% |
| 31 Dec, 23 | 66 | 3.13% | 14,756,868 | -8.16% | 30.13% | 1.93% | 35 | -10.26% | 21 | 75.00% |
| 30 Sep, 23 | 64 | -16.88% | 16,067,868 | -1.98% | 39.54% | 2.16% | 39 | -23.53% | 12 | -7.69% |
| 30 Jun, 23 | 77 | 18.46% | 16,391,912 | 22.72% | 42.77% | 3.52% | 51 | 64.52% | 13 | -38.10% |
| 31 Mar, 23 | 65 | -10.96% | 13,357,414 | -5.06% | 34.85% | 2.51% | 31 | -13.89% | 21 | -4.55% |
| 31 Dec, 22 | 73 | 19.67% | 14,068,972 | -2.19% | 37.27% | 2.59% | 36 | - | 22 | 46.67% |
| 30 Sep, 22 | 61 | 12.96% | 14,383,381 | 10.79% | 37.95% | 3.19% | 36 | 5.88% | 15 | 25.00% |
| 30 Jun, 22 | 54 | 17.39% | 12,982,833 | 5.45% | 34.52% | 3.20% | 34 | 41.67% | 12 | -25.00% |
| 31 Mar, 22 | 46 | 2.22% | 12,312,215 | 1.45% | 32.86% | 1.61% | 24 | -20.00% | 16 | 100.00% |
| 31 Dec, 21 | 45 | -4.26% | 12,136,763 | 22.54% | 45.12% | 6.35% | 30 | 15.38% | 8 | -46.67% |
| 30 Sep, 21 | 47 | -21.67% | 9,904,230 | -1.59% | 26.65% | 2.36% | 26 | -56.67% | 15 | - |
| 30 Jun, 21 | 60 | - | 10,064,753 | - | 33.58% | - | 60 | - | - | - |
Akoya Biosciences Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Akoya Biosciences's stock was made by McKelligon Brian on Jun 12 2024, selling 7,500 shares at $0.30 per share (valued at $2.27K).
Akoya Biosciences Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 8 | 5 | 160.00% |
| Q1 2024 | 13 | 14 | 92.86% |
| Q4 2023 | 5 | 6 | 83.33% |
| Q3 2023 | 2 | - | - |
| Q2 2023 | 16 | 2 | 800.00% |
| Q1 2023 | 16 | 8 | 200.00% |
| Q4 2022 | 4 | 14 | 28.57% |
| Q3 2022 | 1 | 5 | 20.00% |
| Q2 2022 | 13 | 3 | 433.33% |
| Q1 2022 | 5 | 1 | 500.00% |
| Q4 2021 | 5 | 2 | 250.00% |
| Q3 2021 | 1 | 1 | 100.00% |
| Q2 2021 | 6 | 19 | 31.58% |
8 total buy trades, and 5 total sell trades (buy/sell ratio of 1.60%) were made by Akoya Biosciences's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | 2 | - |
| Q1 2024 | - | 3 | - |
| Q4 2023 | - | 3 | - |
| Q3 2023 | 2 | - | - |
| Q2 2023 | 8 | 1 | 800.00% |
| Q1 2023 | - | 2 | - |
| Q4 2022 | - | 10 | - |
| Q3 2022 | - | 4 | - |
| Q2 2022 | - | 1 | - |
| Q1 2022 | - | - | - |
| Q4 2021 | 5 | 2 | 250.00% |
| Q3 2021 | - | - | - |
| Q2 2021 | - | - | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 2 open market sell trades of Akoya Biosciences's stocks.
AKYA Ownership FAQ
Who Owns Akoya Biosciences?
Akoya Biosciences is owned by institutional shareholders (25.18%), insiders (11.60%), and public (63.22%). The largest institutional shareholder of Akoya Biosciences is BLUE WATER LIFE SCIENCE ADVISORS, LP (9.55% of total shares) and the top mutual fund owner is ALGER INSTITUTIONAL FUNDS (0.23% of total shares).
Who are the major institutional shareholders of Akoya Biosciences?
Akoya Biosciences's major institutional shareholders are BLUE WATER LIFE SCIENCE ADVISORS, LP, BLACKROCK INC., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, and SVB WEALTH LLC. The top five shareholders own together 17.77% of the company's share outstanding.
How many Akoya Biosciences shareholders are there?
As of Jun 2024, there are 60 institutional shareholders of Akoya Biosciences.
What percentage of Akoya Biosciences is owned by BLUE WATER LIFE SCIENCE ADVISORS, LP?
BLUE WATER LIFE SCIENCE ADVISORS, LP owns 4.7M shares of Akoya Biosciences, representing 9.55% of the company's total shares outstanding, valued at $10.99M (as of Jun 2024).
What percentage of Akoya Biosciences is owned by BLACKROCK INC?
As of Jun 2024, BLACKROCK INC holds 1.5M shares of Akoya Biosciences (AKYA), compromising 3.05% of the company, valued at $3.51M.
What percentage of Akoya Biosciences is owned by VANGUARD GROUP INC?
VANGUARD GROUP INC is the third largest holder of Akoya Biosciences. The company owns 1.46M of the company's shares outstanding (worth $3.43M).